AzTrials
AzTrials

Diabetes Mellitus, Type 2NCT03143764

Cardiorespiratory Fitness Using Electrically Assisted Bicycles

A study testing Commuting with electrically assisted bicycles in people with Diabetes Mellitus, Type 2, run by University of Bergen at 3 sites in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aimed to examine cycling time and distance when inactive subjects were provided with electrically assisted bicycles, and secondly, to examine changes in cardiorespiratory fitness. Read more about this study

Who is it for?
Ages 18 to 67 yearsHealthy volunteers can take part
Conditions the study is for
Diabetes Mellitus, Type 2
What is being tested?
Commuting with electrically assisted bicycles
How many people
25 participants
Where
3 sitesNorway
Study dates
1 Sep 2014to 1 Dec 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 67 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • -a desire to cycle to work, residence more than 3km from the workplace, and not physically active according to guidelines

Who cannot join

  • -

Trial locations and contacts

3 sites in 1 country.

Norway3 sites
  • Department of Global Public Health and Primary Care, University of Bergen

    Bergen, 5018

  • Department of Public Health, Sport and Nutrition, University of Agder

    Kristiansand

  • Department of Education and Sports Science, University of Stavanger

    Stavanger

Other trials in Norway

About this study

Official title: Bicycle Usage and Cardiorespiratory Fitness Among Inactive Adults Provided With Electrically Assisted Bicycles

This study aimed to examine cycling time and distance when inactive subjects were provided with electrically assisted bicycles, and secondly, to examine changes in cardiorespiratory fitness.

Read the detailed description

Method: Inactive employees in a selection of public and private corporations in three Norwegian cities were invited to participate. Inclusion criteria were: a desire to cycle to work, residence more than 3km from the workplace, and not physically active according to guidelines. There were 25 participants in the study and we provided them all with electrically assisted bicycles fitted with GPS bike computers to record usage. The participants were followed for three to eight months, 226 days on average. Measures of maximal oxygen uptake were performed before and after the intervention. Demographic characteristics and prior transportation habits were reported in a questionnaire at baseline.

Being tested
Commuting with electrically assisted bicycles
Medical subject headings
Diabetes Mellitus, Type 2

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Commuting with electrically assisted bicyclesBehavioural

    25 participants were provided with electrically assisted bicycles fitted with GPS bike computers to record usage

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. examine cycling time

    when inactive subjects were provided with electrically assisted Bicycles for 12 months

    Measured: 12 months

  2. examine cycling distance

    when inactive subjects were provided with electrically assisted Bicycles for 12 months

    Measured: 12 months

Secondary outcomes (1)
  1. examine changes in cardiorespiratory fitness

    Measurements of V02 max pre- post

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 May 2017
  2. Study start1 Sep 2014
  3. Primary completion15 Jun 2015
  4. Study completion1 Dec 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Single group
Model description
Inactive employees in a selection of public and private corporations in three Norwegian cities were invited to participate. Inclusion criteria were: a desire to cycle to work, residence more than 3km from the workplace, and not physically active according to guidelines. There were 25 participants in the study and we provided them all with electrically assisted bicycles fitted with GPS bike computers to record usage. The participants were followed for three to eight months, 226 days on average
Masking
None (open label)
Enrolment
25 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03143764
Sponsor's protocol ID
UBergenElsykkel
Status last verified
May 2017
First submitted
21 Apr 2017
Last updated
8 May 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Commuting with electrically assisted bicycles in people with Diabetes Mellitus, Type 2, run by University of Bergen at 3 sites in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 May 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

examine cycling time (time frame: 12 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in